Evidence map›Paper›PMID 41543523›Full record

ArticleEpilepsia2026

Rethinking drug resistance in focal cortical dysplasia-related epilepsy.

Nathan T Cohen, Chima O Oluigbo, M Scott Perry, William D Gaillard

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Epilepsia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nathan T CohenDepartment of Neurology, Children's National Hospital, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.ORCID https://orcid.org/0000-0002-1410-3487
Chima O OluigboDepartment of Neurosurgery, Children's National Hospital, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.
M Scott PerryDepartment of Neurology, Jane and John Justin Institute for Mind Health, Cook Children's Medical Center, Fort Worth, Texas, USA.ORCID https://orcid.org/0000-0002-1825-846X
William D GaillardDepartment of Neurology, Children's National Hospital, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.ORCID https://orcid.org/0000-0001-5709-0033

Funding

Neurobehavioral Evaluation CoreP50HD105328 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI WILLIAM Davis GAILLARD · 2021 to 2026
$9.3M
Determining network signatures of pharmacoresistance in focal cortical dysplasia-related epilepsyK23NS131522 · NINDS · CHILDREN'S RESEARCH INSTITUTE · PI Nathan Tyler Cohen · 2025 to 2026
$431k
NICHD NIH HHS P50 HD105328NINDS NIH HHS K23 NS131522NINDS NIH HHS K23NS131522
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41543523
PMCPMC13088196

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.